Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Topical NEOSH101 for Androgenetic Alopecia in Men
2006-002757-72Phase 2Completed
- Sponsor
- Neosil
- Start
- Sep 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neosh101 in androgenetic alopecia (AGA) (4 arms), sponsored by Neosil. Primary endpoint: Change in hair density. Started Sep 2006; status: completed.
02
Drugs
neosh101
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2006-002757-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002757-72.